According to a recent study, there is. It found that ‘ endurance performance can be maintained for up to 15 weeks when ...

Pivotal Phase 3 randomized, double-blind, placebo-controlled study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac ...

Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...

A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk ...

A 3D printed cornea restored a patient’s sight in a world first. See how this breakthrough may help millions facing corneal ...

In early experiments, use of the patch resulted in fewer inflammatory signals in the surrounding tissue and a reduction in ...

As of Tuesday, December 09, Dyne Therapeutics, Inc.’s DYN share price has dipped by 12.95%, which has investors questioning if this is right time to buy.

This is a new position for Foresite Capital Management IV, LLC, representing 13.8% of reportable assets under management as ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher ...

The Cleveland Clinic suggests it particularly affects four groups, and research shows complications extending 20 years post-exposure.